BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12354578)

  • 1. Immunosuppression induced by central action of morphine is not blocked by mifepristone (RU 486).
    Liang-Suo J; Gomez-Flores R; Weber RJ
    Life Sci; 2002 Oct; 71(22):2595-602. PubMed ID: 12354578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of interleukin-2 production and downregulation of IL-2 and transferrin receptors on rat splenic lymphocytes following PAG morphine administration: a role in natural killer and T cell suppression.
    Gomez-Flores R; Weber RJ
    J Interferon Cytokine Res; 1999 Jun; 19(6):625-30. PubMed ID: 10433363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray.
    Gomez-Flores R; Weber RJ
    Immunopharmacology; 2000 Jul; 48(2):145-56. PubMed ID: 10936512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulating effects of morphine microinjected into periaqueductal gray.
    Bian TH; Li XY
    Zhongguo Yao Li Xue Bao; 1995 Mar; 16(2):121-4. PubMed ID: 7597910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation mediated by microinjection of morphine into the periaqueductal gray matter of the mesencephalon.
    Suo JL; Weber RJ
    Adv Exp Med Biol; 1998; 437():177-82. PubMed ID: 9666269
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status.
    Lysle DT; Hoffman KE; Dykstra LA
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1533-40. PubMed ID: 8667220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of splenic macrophage functions following acute morphine action in the rat mesencephalon periaqueductal gray.
    Gomez-Flores R; Suo JL; Weber RJ
    Brain Behav Immun; 1999 Sep; 13(3):212-24. PubMed ID: 10469523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The periaqueductal gray matter mediates opiate-induced immunosuppression.
    Weber RJ; Pert A
    Science; 1989 Jul; 245(4914):188-90. PubMed ID: 2749256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity.
    Freier DO; Fuchs BA
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1127-33. PubMed ID: 7932161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of intrathecal morphine-induced immunosuppression by microinjection of naloxone into periaqueductal gray.
    Zhang Y; Du LN; Wu GC; Cao XD
    Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):519-22. PubMed ID: 10437136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses.
    Mellon RD; Bayer BM
    J Pharmacol Exp Ther; 1999 Feb; 288(2):635-42. PubMed ID: 9918569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats.
    Fecho K; Maslonek KA; Dykstra LA; Lysle DT
    J Pharmacol Exp Ther; 1996 May; 277(2):633-45. PubMed ID: 8627540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of brain opiate receptors in the immune-suppressive effect of morphine.
    Shavit Y; Depaulis A; Martin FC; Terman GW; Pechnick RN; Zane CJ; Gale RP; Liebeskind JC
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7114-7. PubMed ID: 3018757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity.
    Carr DJ; Gebhardt BM; Paul D
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1179-86. PubMed ID: 8383741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
    Mellon RD; Bayer BM
    Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism.
    Bayer BM; Daussin S; Hernandez M; Irvin L
    Neuropharmacology; 1990 Apr; 29(4):369-74. PubMed ID: 2160624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute immunosuppressive effects of morphine: lack of involvement of pituitary and adrenal factors.
    Flores LR; Hernandez MC; Bayer BM
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1129-34. PubMed ID: 8138926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the hypothalamic-pituitary-adrenal (HPA) axis contributes to the immunosuppression of mice infected with Angiostrongylus cantonensis.
    Chen AL; Sun X; Wang W; Liu JF; Zeng X; Qiu JF; Liu XJ; Wang Y
    J Neuroinflammation; 2016 Oct; 13(1):266. PubMed ID: 27733201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress-induced modulation of NK activity during influenza viral infection: role of glucocorticoids and opioids.
    Tseng RJ; Padgett DA; Dhabhar FS; Engler H; Sheridan JF
    Brain Behav Immun; 2005 Mar; 19(2):153-64. PubMed ID: 15664788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity.
    Saurer TB; Ijames SG; Lysle DT
    J Neuroimmunol; 2006 Aug; 177(1-2):18-26. PubMed ID: 16766046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.